Company Monitoring Page for Roche

latest headlines for company on cafepharma

UK ‘less interesting’ to pharma because of Brexit – Roche CEO
Pharmaforum
Fri, 09/14/18 - 11:53 pm
Tags:
Brexit, Roche, Severin Schwan, UK
Roche CEO Severin Schwan is keeping his hand on the budget ax
Endpoints
Fri, 09/14/18 - 11:51 am
Tags:
Roche, Genentech, Severin Schwan, R&D, layoffs, reorganization
BIO, Allergan and Roche Call for FDA Flexibility With Patient Experience Data
RAPS.org
Wed, 09/12/18 - 07:16 pm
Tags:
BIO, Allergan, Roche, FDA, patient experience data
MS Society protests NICE rejection of Ocrevus for primary progressive MS
BioCentury
Mon, 09/10/18 - 12:16 am
Tags:
NICE, UK, MS, multiple sclerosis, Ocrevus, ocrelizumab, Roche
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Tags:
Adamis, GSK, Sangamo BioSciences, Roche, Bluebird Bio, ProQR Therapeutics, Geron, Amarin, Palatin, EyeGate, Galactin, Omeros, Atossa Genetics
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
Tags:
biotech, FDA, Roche, Tecentriq, GSK, mepolizumab, Teva Pharmaceutical, fremanezumab, Adamis Pharmaceuticals, Symjepi, Insmed, ALIS, Antares, XYOSTED, Eli Lilly, galcanezumab, Pfizer, dacomitinib
Roche reveals haemophilia drug data ahead of label expansion decision
Pharmaforum
Fri, 08/31/18 - 11:51 am
Tags:
Roche, hemophilia A, FDA, Hemlibra
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Tue, 08/28/18 - 10:03 am
Tags:
Roche, Genentech, Affimed, cancer immunotherapy, drug development
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
Mon, 08/27/18 - 10:02 am
Tags:
AbbVie, JNJ, FDA, Imbruvica, Rituxan, Roche, AstraZeneca, non-Hodgkin's lymphoma, Waldenström’s macroglobulinemia
Once lauded for its clinical success, Roche casts off cardio program inclacumab for a mere $2M to Global Blood Therapeutics
Endpoints
Thu, 08/23/18 - 10:11 am
Tags:
Roche, inclacumab, Global Blood Therapeutics
Roche's Alecensa latest beneficiary of faster China drug approvals
Reuters
Mon, 08/20/18 - 11:37 am
Tags:
Roche, Alecensa. China, lung cancer
As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California
Fierce Pharma
Wed, 08/15/18 - 10:28 pm
Tags:
Roche, Genentech, WARN notice, layoffs, California
US agency to rule on Tecentriq’s most important use
EP Vantage
Wed, 08/15/18 - 11:57 am
Tags:
Roche, Tecentriq, non-squamous non-small cell lung cancer, FDA
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Fierce Pharma
Mon, 08/13/18 - 05:53 pm
Tags:
Novartis, Roche, Xolair, FDA, food allergies
Drug firms fight US government’s Iraq corruption probe
Pharmaforum
Thu, 08/9/18 - 08:46 pm
Tags:
Iraq, DOJ, AstraZeneca, Roche, JNJ, GE, Pfizer
Roche is on the “SurePath” for Cervical Cancer Screening with Approval
Medical Devices and Diagnostics Industry
Sat, 08/4/18 - 12:18 pm
Tags:
Roche, FDA, HPV, SurePath, diagnostics
Roche gets some regulatory love for its breakthrough quest on a PhIII Huntington’s drug
Endpoints
Fri, 08/3/18 - 11:31 pm
Tags:
Roche, EMA, Europe, RG6042, IONIS-HTTRx, Huntington's disease
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
CP Wire
Tue, 07/31/18 - 12:30 pm
Tags:
Ttrazimera, Pfizer, biosimilars, Herceptin, Europe, Roche
On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019
Endpoints
Thu, 07/26/18 - 11:22 am
Tags:
Roche, patents, Herceptin, Cabilly patents
Can Celgene's latest Revlimid win reverse the company's bad-news streak?
Fierce Pharma
Tue, 07/24/18 - 06:00 pm
Tags:
Celgene, Revlimid, clinical trials, Roche, Rituxan, non-Hodgkin lymphoma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.